Home

NICE may change drug rules for end of life

By 2008-11-06T09:00:00

The National Institute for Health and Clinical Excellence wants to apply different rules when deciding whether to recommend expensive drugs for terminally ill patients with rare conditions.

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
  • 10 expert briefings every fortnight (Premium only)

Subscribe

to HSJ

Already a subscriber? Sign into your account here